Neither medication is definitively "safer" overall—the choice depends on specific side effect profiles that matter most to the individual patient.
When comparing Celexa (citalopram) and Wellbutrin (bupropion), both medications have similar overall safety profiles but differ significantly in their specific adverse effects. The American College of Physicians guidelines emphasize that second-generation antidepressants should be selected based on adverse effect profiles, cost, and patient preferences rather than efficacy differences 1.
Key Side Effect Differences
Sexual Dysfunction
Bupropion has a clear advantage for sexual side effects. Bupropion demonstrates significantly lower rates of sexual adverse events compared to SSRIs like citalopram 1, 2. The FDA label for Celexa reports ejaculatory delay in 6.1% of males, decreased libido in 3.8%, and impotence in 2.8% 3. In contrast, bupropion is associated with minimal sexual dysfunction 2, 4.
Gastrointestinal Effects
Citalopram causes more GI side effects. Nausea occurs in 21% of citalopram patients versus 14% with placebo, and is the most common reason for discontinuation 3. Bupropion causes significantly less nausea, diarrhea, and somnolence compared to SSRIs 2.
Seizure Risk
Bupropion carries a higher seizure risk. Weak evidence indicates bupropion may be associated with increased seizure risk, particularly at doses above 450 mg/day 1. It is contraindicated in patients with seizure disorders, brain metastases, or eating disorders 5. Citalopram does not carry this specific warning.
Cardiac Effects
Citalopram has QT prolongation concerns. The FDA issued dose limitations for citalopram (maximum 40 mg/day, 20 mg/day for patients >60 years) due to QT interval prolongation risk 6. However, recent research suggests minimal cardiovascular risk at therapeutic doses ≤60 mg/day 7. Bupropion has minimal cardiac conduction effects and rare orthostatic hypotension 8.
Suicidality
Both carry similar suicidality warnings. As an SSRI, citalopram is associated with increased risk for nonfatal suicide attempts (OR 1.57-2.25) compared to placebo 1. Both medications require monitoring for neuropsychiatric effects including suicidal ideation, particularly in the first 1-2 months 5, 1.
Other Common Side Effects
Citalopram causes more:
- Somnolence (18% vs 10% placebo) 3
- Weight changes (though minimal—0.5 kg loss) 3
- Insomnia (15% vs 14% placebo) 3
Bupropion causes more:
- Activation/agitation (avoid in agitated patients) 9
- Insomnia (give second dose before 3 PM) 9
- Dry mouth 8
Clinical Decision Algorithm
Choose Bupropion when:
- Sexual dysfunction is a concern or has occurred with prior SSRIs
- Patient has comorbid fatigue/low energy (activating properties)
- Patient wants to avoid weight gain
- Patient has comorbid ADHD symptoms
Avoid Bupropion when:
- History of seizures, eating disorders, or brain metastases
- Patient is agitated or has significant anxiety
- Patient takes MAO inhibitors or tamoxifen 5
Choose Citalopram when:
- Patient has comorbid anxiety (SSRIs preferred)
- Seizure risk is a concern
- Patient needs sedating properties for insomnia
- Sexual function is not a priority
Avoid Citalopram when:
- Sexual dysfunction is unacceptable
- Patient is elderly (>60 years) requiring higher doses
- Significant cardiac history with QT concerns
- Patient cannot tolerate GI side effects
Important Caveats
Both medications require close monitoring in the first 1-2 weeks for worsening depression, suicidal ideation, or behavioral changes 1. The overall discontinuation rates due to adverse effects are similar between second-generation antidepressants 10. Neither medication shows superior efficacy—the choice truly hinges on which specific side effects are most tolerable for the individual patient 1.